60611-22-5 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-6-(trifluoromethyl)benzaldehyde is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties. Its unique chemical structure allows for the creation of molecules with targeted actions and improved pharmacological profiles.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Chloro-6-(trifluoromethyl)benzaldehyde is utilized as a precursor in the production of pesticides and other crop protection agents. Its reactivity and properties enable the synthesis of compounds that can effectively control pests and diseases in agriculture, thereby enhancing crop yields and quality.
Used in Chemical and Manufacturing Industries:
2-Chloro-6-(trifluoromethyl)benzaldehyde is employed as a key building block in the synthesis of a wide range of specialty chemicals. Its distinctive chemical structure and reactivity make it a valuable component in the development of new materials and compounds for various applications, including but not limited to, dyes, fragrances, and other industrial chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 60611-22-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,6,1 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60611-22:
(7*6)+(6*0)+(5*6)+(4*1)+(3*1)+(2*2)+(1*2)=85
85 % 10 = 5
So 60611-22-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H4ClF3O/c9-7-3-1-2-6(5(7)4-13)8(10,11)12/h1-4H
60611-22-5Relevant academic research and scientific papers
5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
-
, (2021/05/21)
The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
-
, (2015/08/04)
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF
-
, (2014/03/22)
Disclosed are compounds of Formula I or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
-
, (2014/03/22)
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
